Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Added a Locations section with state listings (Alabama, Florida, Illinois, Indiana, Virginia). Updated the page revision to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T22:31:53.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page now includes a related topics section with Melanoma and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2025-12-16T21:42:03.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Removed Melanoma and related MeSH topic links from the More Information/Related Topics section; these are supplementary navigation items. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-09T19:29:30.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing v3.2.0, which is a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:55:33.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Removed the banner about government funding and operating status. The study details page content remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:24:18.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added melanoma and related topics, including MedlinePlus Genetics, to the study page's contextual content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-11T03:08:24.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.